A case report of vesicovaginal fistula following Bevacizumab without pelvic disease and radiochemotherapy

BACKGROUND: Bevacizumab has gradually become an important adjuvant therapy for many advanced tumors including lung cancer. Although it can improve the survival of many cancer patients, it also brings many adverse reactions, including fistula formation. However, vesicovaginal fistula in the absence o...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Junlong, Chen, Yu, Liang, Yueyou, Cao, Mingxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459572/
https://www.ncbi.nlm.nih.gov/pubmed/36093527
http://dx.doi.org/10.21037/tcr-22-251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459572/
https://www.ncbi.nlm.nih.gov/pubmed/36093527
http://dx.doi.org/10.21037/tcr-22-251

Ejemplares similares